The paint industry, long an oligopolistic stronghold with high entry barriers, is undergoing a shift. The entry of new players has intensified competition, leaving established players scrambling to defend their turf.
To retain or expand market share, both incumbents and new entrants are ramping up capacities, expanding dealer networks, and are set to boost advertising spends. But this aggressive push is straining profitability, especially with disruptive pricing from entrants like Birla Opus threatening earnings growth. Companies face a tough choice: prioritize market share or protect margins.
هذه القصة مأخوذة من طبعة January 02, 2025 من Mint Bangalore.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة January 02, 2025 من Mint Bangalore.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars
Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects
DIAL drops plea over Hindon ops expansion
Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.
Auto sales rise 9% in 2024 despite headwinds: Fada
Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec
Razorpay Charts Return to India; Eyes Expansion, IPO
Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years
Bank profits set to moderate in FY26 as bad assets rise
Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier
Lloyds Metals shines on likely gains from acquisition, capex
Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.
Another tough year for FMCG?
Feeling blue
Your fancy, new ETF might be a little too fancy
Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good
Risks to economy escalating in 2025, cautions SBICAPS
Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report
Intas Pharma bags another overseas company
Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.
